J Korean Med Sci.  2021 Dec;36(49):e345. 10.3346/jkms.2021.36.e345.

Analysis of PubMed and KoreaMed Indexed Korean Publications on COVID-19

Affiliations
  • 1Department of Neurology, Seoul National University College of Medicine & Associate Editor, Journal of Korean Medical Science, Seoul, Korea
  • 2Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea & Associate Editor, Journal of Korean Medical Science, Seoul, Korea
  • 3Editorial Researcher, Journal of Korean Medical Science, Seoul, Korea
  • 4Department of Tropical Medicine and Parasitology, Seoul National University College of Medicine & Editor-in-Chief, Journal of Korean Medical Science, Seoul, Korea

Abstract

During the coronavirus disease 2019 (COVID-19) pandemic, publications on the disease have exploded globally. The present study analyzed PubMed and KoreaMed indexed COVID-19 publications by Korean researchers from January 1, 2020 to August 19, 2021. A total of 83,549 COVID-19 articles were recorded in PubMed and 1,875 of these were published by Korean authors in 673 journals (67 Korean and 606 overseas journals). The KoreaMed platform covered 766 articles on COVID-19, including 612 by Korean authors. Among the Journal of Korean Medical Science (JKMS) articles on COVID-19, PubMed covered 176 and KoreaMed 141 documents. Korean researchers contributed to 2.2% of global publications on COVID-19 in PubMed. The JKMS has published most articles on COVID-19 in Korea.

Keyword

Bibliographies as Topic; COVID-19; Periodicals as Topic; Publications; Korean Researcher; Journal of Korean Medical Science

Figure

  • Fig. 1 Number of monthly publications on coronavirus disease 2019 by Korean authors.


Reference

1. Coronavirus disease statistics. Accessed December 4, 2021. https://www.google.com/search?q=coronavirus+stats+worldwide&newwindow .
2. Korea Disease Control and Prevention Agency. Coronavirus (COVID-19), Republic of Korea. Updated 2021. Accessed December 13, 2021. http://ncov.mohw.go.kr/en/bdBoardList.do?brdId=16&brdGubun=161&dataGubun=&ncvContSeq=&contSeq=&board_id=&gubun= .
3. Munro AP, Janani L, Cornelius V, Aley PK, Babbage G, Baxter D, et al. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. Lancet. Forthcoming. 2021; DOI: 10.1016/S0140-6736(21)02717-3.
4. Kim JY, Choe PG, Oh Y, Oh KJ, Kim J, Park SJ, et al. The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures. J Korean Med Sci. 2020; 35(5):e61. PMID: 32030925.
Article
5. JKMS. Number of total publications. Updated 2021. Accessed December 4, 2021. https://jkms.org/index.php?main=COVID-19 .
6. Hong ST. Fostering strategic changes in publishing: Journal of Korean Medical Science in 2018. J Korean Med Sci. 2018; 33(1):e8. PMID: 29215817.
Article
7. Korean Society of Infectious Diseases, Korean Society of Pediatric Infectious Diseases, Korean Society of Epidemiology, Korean Society for Antimicrobial Therapy, Korean Society for Healthcare-associated Infection Control and Prevention, Korea Centers for Disease Control and Prevention. Report on the epidemiological features of coronavirus disease 2019 (COVID-19) outbreak in the Republic of Korea from January 19 to March 2, 2020. J Korean Med Sci. 2020; 35(10):e112. PMID: 32174069.
8. Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ, et al. Case of the index patient who caused tertiary transmission of coronavirus disease 2019 in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR. J Korean Med Sci. 2020; 35(6):e79. PMID: 32056407.
Article
9. Ahn JY, Sohn Y, Lee SH, Cho Y, Hyun JH, Baek YJ, et al. Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory distress syndrome in Korea. J Korean Med Sci. 2020; 35(14):e149. PMID: 32281317.
Article
10. Lee Y, Min P, Lee S, Kim SW. Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. 2020; 35(18):e174. PMID: 32383370.
Article
11. Kim ES, Chin BS, Kang CK, Kim NJ, Kang YM, Choi JP, et al. Clinical course and outcomes of patients with severe acute respiratory syndrome coronavirus 2 infection: a preliminary report of the first 28 patients from the Korean cohort study on COVID-19. J Korean Med Sci. 2020; 35(13):e142. PMID: 32242348.
Article
12. Park WB, Kwon NJ, Choi SJ, Kang CK, Choe PG, Kim JY, et al. Virus isolation from the first patient with SARS-CoV-2 in Korea. J Korean Med Sci. 2020; 35(7):e84. PMID: 32080990.
Article
13. Kim JY, Ko JH, Kim Y, Kim YJ, Kim JM, Chung YS, et al. Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea. J Korean Med Sci. 2020; 35(7):e86. PMID: 32080991.
Article
14. Yoon JG, Yoon J, Song JY, Yoon SY, Lim CS, Seong H, et al. Clinical significance of a high SARS-CoV-2 viral load in the saliva. J Korean Med Sci. 2020; 35(20):e195. PMID: 32449329.
Article
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr